Companies
Great American Insurance
confirmed via ERRRA trade-press coverage of a GenAI-exclusion article specific to its IP insurance line — medium confidence, on-topic evidence of active biotech-relevant underwriting.
- Country
- United States
GenAI-exclusion IP insurance
Coverage
| EU | US | |
|---|---|---|
| market-access-commercial | ✓ | ✓ |
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biotech IP insurance | market-access-commercial | High | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.